Company performance
Add to research
Current Price
as of Apr 17, 2025$0.55
P/E Ratio
N/A
Market Cap
$13.36M
Description
Add to research
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. The firm also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. Its products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.
Metrics
Add to research
Overview
- HQTucson, AZ
- SectorHealth Technology
- IndustryMedical Specialties
- TickerAXDX
- Price$0.549-1.81%
Trading Information
- Market cap$13.36M
- Float60.73%
- Average Daily Volume (1m)68,770
- Average Daily Volume (3m)42,873
- EPS-$2.15
Company
- Revenue$11.70M
- Rev growth (1yr)-2.99%
- Net income-$50.04M
- Gross margin23.12%
- EBITDA margin-272.60%
- EBITDA-$31.89M
- EV$78.24M
- EV/Revenue6.69
- P/EN/A
- P/S1.06
- P/BN/A
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Factset Street Account
Accelerate Diagnostics reports Q3 EPS $0.06 vs year-ago ($1.83) ($5.90, 0.00) (2023-11-09T21:20:55Z)
Earnings Calls
Factset